We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.75B
Cap. Flow %
-19.89%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.76%
3 Healthcare 14.3%
4 Real Estate 8.12%
5 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUMA icon
601
Humacyte
HUMA
$197M
$1.94M 0.02%
595,172
-504,828
-46% -$1.94M
AXTA icon
602
Axalta
AXTA
$8.13B
$1.94M 0.02%
92,070
CERO
603
DELISTED
CERo Therapeutics
CERO
$1.93M 0.02%
95
-10
-10% -$201K
LION
604
DELISTED
Lionheart III Corp Class A Common Stock
LION
$1.93M 0.02%
190,898
-19,111
-9% -$192K
OPTX icon
605
Syntec Optics
OPTX
$317M
$1.92M 0.02%
190,898
-19,111
-9% -$192K
TYGO icon
606
Tigo Energy
TYGO
$96M
$1.92M 0.02%
190,898
-19,111
-9% -$191K
SWSS
607
DELISTED
Clean Energy Special Situations Corp. Common stock
SWSS
$1.9M 0.02%
381,796
-38,222
-9% -$190K
NGC
608
DELISTED
Northern Genesis Acquisition Corp. III
NGC
$1.9M 0.02%
194,086
-19,430
-9% -$190K
FRBN
609
DELISTED
Forbion European Acquisition Corp. Class A Ordinary Shares
FRBN
$1.9M 0.02%
187,163
-18,737
-9% -$188K
WEL
610
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.89M 0.02%
187,163
-18,737
-9% -$188K
HCMA
611
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$1.89M 0.02%
187,163
-18,737
-9% -$188K
RCL icon
612
PUT
Royal Caribbean
RCL
$85.6B
$1.88M 0.02%
54,200
RNW icon
613
ReNew
RNW
$2.27B
$1.88M 0.02%
311,739
-1,713
-0.5% -$11.7K
CPTK
614
DELISTED
Crown PropTech Acquisitions
CPTK
$1.88M 0.02%
188,968
-18,997
-9% -$188K
FLYX icon
615
flyExclusive
FLYX
$62.7M
$1.86M 0.02%
190,155
-19,036
-9% -$186K
ARYE
616
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$1.84M 0.02%
187,163
-18,737
-9% -$183K
PLTR icon
617
Palantir
PLTR
$409B
$1.83M 0.02%
225,000
-25,000
-10% -$222K
BTM
618
DELISTED
Bitcoin Depot
BTM
$1.82M 0.02%
26,261
-2,629
-9% -$183K
LITT
619
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
$1.82M 0.02%
186,126
-18,633
-9% -$182K
ITQ
620
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$1.81M 0.02%
182,323
-19,111
-9% -$189K
KNSA icon
621
Kiniksa Pharmaceuticals
KNSA
$5.91B
$1.81M 0.02%
+140,962
New +$1.61M
JNJ icon
622
Johnson & Johnson
JNJ
$619B
$1.81M 0.02%
+11,073
New +$1.87M
SYK icon
623
Stryker
SYK
$130B
$1.81M 0.02%
8,925
-5,800
-39% -$1.22M
NBIX icon
624
Neurocrine Biosciences
NBIX
$16.7B
$1.81M 0.02%
17,003
-20,200
-54% -$2.05M
NFYS
625
DELISTED
Enphys Acquisition Corp.
NFYS
$1.79M 0.02%
183,827
-18,403
-9% -$179K

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.75B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.